| Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP (NCT03252457) | Shandong University | 2018-09-01 |
| Rituximab Combining Bortezomib Versus Rituximab in Management of ITP (NCT03443570) | Shandong University | 2018-03-01 |
| A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP) (NCT03275454) | Bioverativ, a Sanofi company | 2017-08-14 |
| The PROLONG Trial - Rituximab Maintenance Therapy in ITP (NCT03010202) | Ostfold Hospital Trust | 2016-12-01 |
| Regulatory B Cells and Chronic Immune Thrombocytopenia (NCT02891109) | University Hospital, Brest | 2015-01-01 |
| Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects (NCT02281370) | GlaxoSmithKline | 2014-11-05 |
| A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients (NCT02403440) | Jiangsu HengRui Medicine Co., Ltd. | 2014-04-01 |
| Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). (NCT02009761) | Boehringer Ingelheim | 2013-12-18 |
| A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) (NCT02201290) | Novartis Pharmaceuticals | 2013-06-18 |
| Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) (NCT01610180) | Fondazione Progetto Ematologia | 2012-06-01 |
| Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia (NCT01317966) | Ming Hou | 2011-03-01 |
| Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects (NCT01327872) | Eisai Inc. | 2011-02-01 |
| High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) (NCT01356511) | Shandong University | 2010-09-01 |
| The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. (NCT01101295) | Henri Mondor University Hospital | 2010-04-01 |
| The Study of Different Dose Rituximab in the Treatment of ITP (NCT03258866) | Shandong University | 2010-01-01 |
| Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP) (NCT00828750) | GlaxoSmithKline | 2008-05-01 |
| Study of Veltuzumab (hA20) at Different Doses in Patients With ITP (NCT00547066) | Gilead Sciences | 2007-11-01 |
| Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP) (NCT00540423) | GlaxoSmithKline | 2007-09-01 |
| Eltrombopag Taste Testing in Healthy Adult Volunteers (NCT00487968) | GlaxoSmithKline | 2007-05-01 |
| Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) (NCT00441090) | Eisai Inc. | 2007-02-01 |
| Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) (NCT00706342) | Rigel Pharmaceuticals | 2007-01-01 |
| Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) (NCT00372892) | Hamilton Health Sciences Corporation | 2006-09-01 |
| Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP (NCT00220727) | Grifols Therapeutics LLC | 2003-07-01 |
| Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia (NCT02334813) | University Hospital, Essen | 2002-07-01 |
| Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura (NCT00005652) | University of Alabama at Birmingham | 2000-12-01 |
| An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers (NCT00005570) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-04-01 |